Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iterum Therapeutics (ITRM) Other Accumulated Expenses (2017 - 2022)

Historic Other Accumulated Expenses for Iterum Therapeutics (ITRM) over the last 6 years, with Q3 2022 value amounting to $1.9 million.

  • Iterum Therapeutics' Other Accumulated Expenses fell 4118.36% to $1.9 million in Q3 2022 from the same period last year, while for Sep 2022 it was $1.9 million, marking a year-over-year decrease of 4118.36%. This contributed to the annual value of $3.0 million for FY2021, which is 1684.27% down from last year.
  • As of Q3 2022, Iterum Therapeutics' Other Accumulated Expenses stood at $1.9 million, which was down 4118.36% from $2.0 million recorded in Q2 2022.
  • Over the past 5 years, Iterum Therapeutics' Other Accumulated Expenses peaked at $4.3 million during Q2 2021, and registered a low of $325000.0 during Q2 2018.
  • Its 5-year average for Other Accumulated Expenses is $2.4 million, with a median of $2.9 million in 2019.
  • Per our database at Business Quant, Iterum Therapeutics' Other Accumulated Expenses skyrocketed by 48466.26% in 2019 and then crashed by 5218.21% in 2022.
  • Iterum Therapeutics' Other Accumulated Expenses (Quarter) stood at $954000.0 in 2018, then soared by 218.87% to $3.0 million in 2019, then grew by 18.28% to $3.6 million in 2020, then decreased by 16.84% to $3.0 million in 2021, then crashed by 35.23% to $1.9 million in 2022.
  • Its Other Accumulated Expenses was $1.9 million in Q3 2022, compared to $2.0 million in Q2 2022 and $2.3 million in Q1 2022.